Latest "At Pappas Ventures" News Stories

13:24 EDT 25th September 2018 | BioPortfolio

Here are the most relevant search results for "At Pappas Ventures" found in our extensive news archives from over 250 global news sources.

More Information about At Pappas Ventures on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about At Pappas Ventures for you to read. Along with our medical data and news we also list At Pappas Ventures Clinical Trials, which are updated daily. BioPortfolio also has a large database of At Pappas Ventures Companies for you to search.

Showing "Pappas Ventures" News Articles 1–25 of 1,100+

Tuesday 25th September 2018

Zillion Appoints Healthcare Veteran Heather Provino to Board of Directors

Zillion, a leading health behavior architecture company, is pleased to announce the appointment of Heather Provino as a new member of the organization’s Board of Directors. “Heather is an invaluable addition to Zillion’s Board of Directors,” said Brent Wilkinson, CEO of Zillion. “The depth of her healthcare experience and strategic insig... Adds Experienced Drug Hunter Mark Herbert to Management Team

Pharmaceutical outsourcing marketplace adds Chief Business Officer to oversee company’s rapid worldwide expansion, the life science industry’s leading online marketplace for outsourced research, announced today the appointment of Mark Herbert to its senior leadership team. As the company’s chief business officer, he will focus on co...

Morphic Therapeutic Announces $80 Million Financing to Advance Next-Generation Oral Integrin Therapeutics Through Clinical Proof of Concept

Series B financing led by Omega Funds and Novo Holdings Financing to enable the initiation of IND-enabling and clinical studies in 2019 Morphic Therapeutic, a biotechnology company developing a new generation of oral integrin therapies, announced today that it has completed a $80 million Series B financing to fund its two lead programs through...

uBiome raises $83m financing to advance product portfolio

OS Fund led the round, with participation from 8VC, Y Combinator, Dentsu Ventures, and additional new and existing investors. The microbiome plays a vital role in every aspect The post uBiome raises $83m financing to advance product portfolio appeared first on Compelo Medical Devices.

Monday 24th September 2018

MODE Raises $3 Million in Series A Funding Led by True Ventures

SAN MATEO, Calif., Sept. 24, 2018 /PRNewswire/ -- Silicon Valley startup MODE today announced it has raised $3 million in Series A funding led by Read more...

CareStack secures $16M to enhance cloud-based platform for dental offices

In addition to the funding, which was led by Accel, Eight Roads Ventures and F-Prime Capital Partners, the company announced it has opened a new office in Cambridge, Massachusetts.

MedTech Innovator Announces Newest Industry Partners

Nonprofit Brings on Industry Leaders Amgen, BTG, EdgeOne Medical, Fujikura, HOYA, NIPRO, Nordson Medical, and W.L. Gore MedTech Innovator, the premier nonprofit startup accelerator in the medical technology industry, today announced eight new partnerships with

Google Assistant Investment Program Invests in Aiva Health, First Voice Platform for End-to-End Care

LA-based Start-up Launches AI-Powered Voice Assistant Connecting Patients and Seniors with their Caregivers in Hospitals and Assisted Living Communities Today, Aiva Health announced an investment from the Google Assistant Investment Program -- the program’s first foray into

BayCross Capital Advises Renovia on $42.3M Financing

BayCross Capital Group, LLC (“BayCross”), a consulting and advisory firm specializing in capital optimization as well as debt and equity raises, is pleased to announce that it advised Renovia Inc (“Renovia”), a company dedicated to discovering and delivering first-line digital therapeutic and diagnostic devices for women with pelvic floor disorders...

Lumos Pharma Acquires Candidate for Oral Treatment of Growth Hormone Deficiency

Lumos Pharma, Inc., a clinical stage biopharmaceutical company focused on development and commercialization of therapeutics for rare and neglected diseases, today announced that it has acquired the license for LUM-201, an investigational orally administered small molecule that promotes secretion of growth hormone from the pituitary gland, from Ammonett Pha...

New Study Reveals the Importance of Active-DHA in the Developing Brain

New research published in PLOS Biology unleashes possibilities for new innovations to support brain health Vanteres, an innovative biotech company leveraging its biomedical research expertise to develop actively transported lysophospholipids, announces new evidence that demonstrates the critical role of LPC-DHA in normal fetal and infant brain d...

BVGH’s African Access Initiative Featured at Biden Cancer Summit

BIO Ventures for Global Health (BVGH) was featured at last week’s Biden Cancer Summit, hosted by Vice President Joe Biden and Dr. Jill Biden, for its commitment to addressing Africa’s long under-recognized

Friday 21st September 2018

Marapharm Ventures Aktie: Nichts als rote Vorzeichen!

An Kursverluste dürften die Anleger von Marapharm Ventures sich mittlerweile gewöhnt haben, immerhin hängt der Titel schon das ganze Jahr über in einem mehr als deutlichen Abwärtstrend fest. An die...

Biotech Startup uBiome Raises $83M to Expand World’s Largest Human Microbiome Database

uBiome, a microbial genetics company leveraging artificial intelligence to develop wellness products, clinical tests, and therapeutics based on the microbiome, today announced it has raised $83 million in Series C funding. The round was led by OS Fund, with participation from 8VC, Y Combinator, Dentsu Ventures, and additional new and existing investors. Now, uBiome is ... Read More

b-ONE Ortho Receives U.S. FDA 510(k) Clearance for Total Hip System

b-ONE Ortho Corp., an emerging orthopedic technology company dedicated to the development of innovative healthcare solutions, today announced it has received 510(k) clearance for its first device, the b-ONETM Total Hip System, from the U.S. Food and Drug Administration (FDA). The b-ONETM Total Hip System is a cementless total hip system with advan...

CareStack™ Announces Completion of $16 Million Financing to Expand Cloud-Based Enterprise Platform for Dental Practices

Company Opens New Technology Development Office in the Cambridge Innovation Center CareStack™, a cloud-based technology platform for the dental industry, today announced it has completed $16 million in funding led by Accel, F-Prime Capital Partners, and Eight Roads Ventures. The company will use the ...

MicuRx Announces Receipt of FDA’s QIDP and Fast Track Designations for Contezolid and Contezolid Acefosamil

MicuRx Pharmaceuticals, Inc. today announced the receipt of the qualified infectious disease product (QIDP) classification and grant of fast track status by the U.S. Food and Drug Administration (FDA) for contezolid (MRX-I) and its prodrug contezolid acefosamil (MRX-4) for the treatment of acute bacterial skin and skin structure infections (ABSSSI). ...

uBiome Announces $83 Million Series C Financing

uBiome Will Expand World’s Largest Human Microbiome Database and Advance Product Portfolio, Including Drug Discovery & Development uBiome, the leader in microbial genomics, today announced the Company has raised $83 million in Series C financing. OS Fund led the round, with participation from 8VC, Y Combinator, Dentsu Ventures, and additional new...

Innovent Presents Clinical Data of Anti-PD-1 Antibody Sintilimab in Patients with Advanced Malignant Neuroendocrine Tumors at Annual Meeting of the Chinese Society of Clinical Oncology

SUZHOU, China, Sept. 21, 2018 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent), a world-class China-based biopharmaceutical company that develops and commercializes high quality drugs, today presented clinical trial data from a phase Ib clinical trial (NCT02937116) that treated patients with neuroendocrine tumors (NET) who have failed of standard therapy with single agent sintilimab, a fully hu...

Thursday 20th September 2018

Andy Slavitt’s Town Hall Ventures raises $115M

Town Hall Ventures, the investment firm started by former CMS administrator Andy Slavitt, has raised $115 million.

Town Hall Ventures Close First Fund at $115 Million

David Raths, Contributing EditorTown Hall Ventures, an investment firm built to address the healthcare challenges of the most vulnerable Americans, has closed its first fund at $115 million.

Marapharm Ventures Aktie: Was ist davon zu halten?

Mitten in einem anhaltenden Abwärtstrend macht die Aktie von Marapharm Ventures am Donnerstagmorgen mit Kursgewinnen von knapp 12 Prozent auf sich aufmerksam. Das hilft dem Papier, sich wieder bis ...

Andy Slavitt’s Town Hall Ventures secures $115M for first fund

Co-founded by former CMS administrator Andy Slavitt, the investment firm, which is focused on vulnerable populations covered by Medicare and Medicaid, also made new investments in three companies: Landmark Health, Bright Health and Strive Health.

MCG Health and Cadalys Present Evidence-Based Care Management at Dreamforce 2018

Industry leaders to speak about disease management solution at Salesforce annual conference SEATTLE, and SAN FRANCISCO (PRWEB) September 20, 2018 MCG Health, part of the Hearst Health network and a leading provider of informed care strategies, and Cadalys, a software innovator with Salesforce® expertise, will present their co-developed solution, Cadalys Care (Informed by MCG), at Salesforce...

Wednesday 19th September 2018

2018 BioCap Conference – Call for Pitches Competition Finalists Announced

BioCap is the only specialist life science investment and showcase conference in the North of England. Now in it’s seventh year the BioCap Conference provides a unique meeting place connecting investors, companies who are seeking finance and those who have a track record of raising finance. As part of the conference, we continue to host the popular pitching competition. Aimed at established...

Quick Search


News Quicklinks